Where the Money Goes

You are here

ALSF Childhood Cancer Research Grants

With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,500 funded projects below.

Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.

You can learn about ALSF's grant review process here.

Support This Research

Jump to search filters

ALSF Funded Research Projects

Project Title	Institution / Principal Investigator(s)	Grant Type	Year	State
Immunotherapy for Pediatric Atypical Teratoid/Rhabdoid Tumor	Baylor College of Medicine / William Decker, PhD	Reach Grants	2013	Texas
B-lapachone as a Novel Targeted Therapy for ATRTs and other Pediatric Cancers	University of Texas Southwestern Medical Center / James Amatruda, MD, PhD	Reach Grants	2013	Texas
Development of a Novel Mer Tyrosine Kinase Inhibitor for Treatment of ALL	University of Colorado Denver / Doug Graham, MD, PhD	Reach Grants	2013	Colorado
Novel Strategy for Reducing Radiation-Induced Morbidity and Treating Recurrent Medulloblasoma	Massachusetts General Hospital / Rakesh Jain, PhD	Reach Grants	2013	Massachusetts
Targeting RNA Helicase DDX3 to Treat Recurrent High Grade Sarcoma	The Johns Hopkins University School of Medicine / David Loeb, MD, PhD	Reach Grants	2013	Maryland
Preclinical Development of Targeted Therapy for Neuroblastoma with ALK and CDK4/6 Dual Pathway Inhibition	Children’s Hospital of Philadelphia / Yael Mossé, MD	Reach Grants	2013	Pennsylvania
Epigenomics of High Risk Pediatric T Cell Leukemia	New York University School of Medicine / Iannis Aifantis, PhD	Reach Grants	2013	New York
Development of a Pharmacodynamic Marker of EWS-FLI1 Activity to Aid in the Clinical Translation of Targeted Therapies for Ewing sarcoma	Van Andel Research Institute / Patrick Grohar, MD, PhD	Reach Grants	2013	Michigan
Stroma Biology Identifies Heparin as a Differentiating Agent in Neuroblastoma	Duke University Medical Center / Gerard Blobe, MD, PhD	Reach Grants	2013	North Carolina
Neural Stem Cell-Mediated Drug Delivery for Targeted Treatment of Medulloblastoma	Beckman Research Institute of City of Hope / Margarita Gutova, MD	Reach Grants	2013	California

Pages